Skip to content
Insider tapeLive · 3:37 PM ET
My stocks

Arch Venture Fund X, L.P.

At a glance: Arch Venture Fund X, L.P. is 10% Owner at Aspen Neuroscience (ASPE). Their latest SEC Form 4, filed Nov 2, 2026, reported a purchase of $1000K. On file: 3 purchase lines ($20.0M) and 0 sale lines ($0).

10% Owner at Aspen Neuroscience, Inc. (ASPE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3.7M
Total bought / sold$20.0M / $0

Every purchase since 2024

From the SEC's insider data sets: each open-market buy by Arch Venture Fund X, L.P., matched to how the stock did over the next 90 days against the S&P 500.

1 of 1 buy beat the S&P 500 (100%), median +15.7% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
SANAFeb 12, 2024+15.7%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 2SEC ASPEAspen Neuroscience, Inc. Buy 66,666new position $15.00 $1000K -18.7%
Nov 2SEC ASPEAspen Neuroscience, Inc. Buy 66,667new position $15.00 $1.0M -18.7%
Nov 2SEC ASPEAspen Neuroscience, Inc. Buy 1,200,000new position $15.00 $18.0M -18.7%
  • Buy

    10% Owner Arch Venture Fund X, L.P. bought $1000K of ASPE at $15.00 — first open-market purchase in our records; opens a new position.

  • Buy

    10% Owner Arch Venture Fund X, L.P. bought $1.0M of ASPE at $15.00 — opens a new position.

  • Buy

    10% Owner Arch Venture Fund X, L.P. bought $18.0M of ASPE at $15.00 — largest purchase by this insider in our records; opens a new position.